Blum K - Search Results

1

Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.

Chen TJ, Blum K, Chen AL, Bowirrat A, Downs WB, Madigan MA, Waite RL, Bailey JA, Kerner M, Yeldandi S, Majmundar N, Giordano J, Morse S, Miller D, Fornari F, Braverman ER. Chen TJ, et al. Among authors: blum k. J Psychoactive Drugs. 2011 Apr-Jun;43(2):108-27. doi: 10.1080/02791072.2011.587393. J Psychoactive Drugs. 2011. PMID: 21858957

2

Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Blum K, et al. Pharmacogenetics. 1995 Jun;5(3):121-41. doi: 10.1097/00008571-199506000-00001. Pharmacogenetics. 1995. PMID: 7550364 Review.

3

The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theorem.

Blum K, Wood RC, Braverman ER, Chen TJ, Sheridan PJ. Blum K, et al. Funct Neurol. 1995 Jan-Feb;10(1):37-44. Funct Neurol. 1995. PMID: 7649500 Review.

4

Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 allele.

Blum K, Braverman ER, Dinardo MJ, Wood RC, Sheridan PJ. Blum K, et al. Pharmacogenetics. 1994 Dec;4(6):313-22. doi: 10.1097/00008571-199412000-00004. Pharmacogenetics. 1994. PMID: 7704037

5

Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics: a reappraisal.

Blum K, Sheridan PJ, Wood R, Braverman ER. Blum K, et al. Eur Arch Psychiatry Clin Neurosci. 1995;245(1):50-2. doi: 10.1007/BF02191544. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7786911 No abstract available.

6

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG, Comings DE. Blum K, et al. J R Soc Med. 1996 Jul;89(7):396-400. doi: 10.1177/014107689608900711. J R Soc Med. 1996. PMID: 8774539 Free PMC article. Review.

7

Substance use disorder exacerbates brain electrophysiological abnormalities in a psychiatrically-ill population.

Braverman ER, Blum K. Braverman ER, et al. Among authors: blum k. Clin Electroencephalogr. 1996;27(4 Suppl):5-27. doi: 10.1177/1550059496027s0402. Clin Electroencephalogr. 1996. PMID: 8902324

8

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Blum K, Braverman ER, Holder JM, Lubar JF, Monastra VJ, Miller D, Lubar JO, Chen TJ, Comings DE. Blum K, et al. J Psychoactive Drugs. 2000 Nov;32 Suppl:i-iv, 1-112. doi: 10.1080/02791072.2000.10736099. J Psychoactive Drugs. 2000. PMID: 11280926 Review.

9

P300 (latency) event-related potential: an accurate predictor of memory impairment.

Braverman ER, Blum K. Braverman ER, et al. Among authors: blum k. Clin Electroencephalogr. 2003 Jul;34(3):124-39. doi: 10.1177/155005940303400306. Clin Electroencephalogr. 2003. PMID: 14521274 Clinical Trial.

10

Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.

Chen TJ, Blum K, Payte JT, Schoolfield J, Hopper D, Stanford M, Braverman ER. Chen TJ, et al. Among authors: blum k. Med Hypotheses. 2004;63(3):538-48. doi: 10.1016/j.mehy.2004.02.051. Med Hypotheses. 2004. PMID: 15288384 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

853 results

Search Page

Filters